INTRODUCTION
This Rule 13e-3 Transaction Statement on Schedule 13E-3, together with the
exhibits and annexes attached hereto (this Schedule 13E-3), is being filed by AVX Corporation, a Delaware corporation (the Company), the issuer of the common stock that is the subject of the Rule 13e-3 transaction described below.
This Schedule 13E-3 relates to the cash tender offer by Arch Merger Sub Inc., a
Delaware corporation (Purchaser), and a wholly owned subsidiary of Kyocera Corporation, a joint stock corporation incorporated under the laws of Japan (Parent), to acquire all of the outstanding
shares of common stock, par value $0.01 per share (the Shares), of the Company that Parent does not already own at an offer price per Share equal to $21.75, net to the seller in cash, without interest and subject to
deduction for any required withholding taxes. The Offer (as defined below) is being made pursuant to the Agreement and Plan of Merger, dated as of February 21, 2020, (together with any amendments or supplements thereto, the Merger
Agreement), by and among the Company, Parent and Purchaser. The Merger Agreement provides, among other things, that as soon as practicable after and on the same date as the consummation of the Offer and subject to the satisfaction or
waiver (to the extent waivable) of the terms and conditions of the Merger Agreement, Purchaser will be merged with and into the Company (the Merger), without a vote of the stockholders of the Company in accordance with
Section 251(h) of the General Corporation Law of the State of Delaware (the DGCL), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. The terms of the Offer, and the
conditions to which it is subject, are set forth in the combined Tender Offer Statement and Rule 13e-3 Transaction Statement filed under cover of Schedule TO by Purchaser and Parent on March 2, 2020 (as
amended or supplemented from time to time, the Schedule TO), which contain as exhibits an Offer to Purchase dated March 2, 2020 (the Offer to Purchase, and the related Letter of Transmittal
(the Letter of Transmittal), which together with the Offer to Purchase, as each of them may be amended or supplemented from time to time, constitutes the "Offer").
In response to the Offer, the Company filed a Solicitation/Recommendation Statement on Schedule 14D-9 on March 2,
2020 (together with any exhibits and annexes attached thereto, the Schedule 14D-9). The information contained in the Schedule 14D-9 and the
Offer to Purchase, including all schedules, annexes and exhibits thereto, copies of which are attached as exhibits hereto, is expressly incorporated by reference to the extent such information is required in response to the items of this Schedule 13E-3, and is supplemented by the information specifically provided herein. The responses to each item in this Schedule 13E-3 are qualified in their entirety by the
information contained in the Schedule 14D-9 and the Offer to Purchase. All information contained in this Schedule 13E-3 concerning the Company, Parent and Purchaser has
been provided by such person and not by any other person. All capitalized terms used in this Schedule 13E-3 without definition have the meanings ascribed to them in the Schedule
14D-9.
ITEM 1.
|
SUMMARY TERM SHEET.
|
The information set forth in the Offer to Purchase under the heading Summary Term Sheet is incorporated herein by reference.
ITEM 2.
|
SUBJECT COMPANY INFORMATION.
|
(a) Name and Address
The
information set forth in the Schedule 14D-9 under the heading Item 1. Subject Company Information - Name and Address is incorporated herein by reference.
(b) Securities
The information
set forth in the Schedule 14D-9 under the heading Item 1. Subject Company Information - Securities is incorporated herein by reference.
2